Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin

Hematology

Volumn 17, Issue 6, 2012, Pages 350-354

  Girolami, A ^a   Scarparo, P ^a   Bonamigo, E ^a   Treleani, M ^a   Lombardi, A M ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

FVII activity discrepancies; FVII deficiency; Tissue thromboplastins

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN; COW; EXON; GENE MUTATION; HOMOZYGOSITY; HUMAN; PLACENTA; PRIORITY JOURNAL; RABBIT;

ANIMALS; FACTOR VII; FACTOR VII DEFICIENCY; HOMOZYGOTE; HUMANS; RABBITS; THROMBOPLASTIN; TREATMENT OUTCOME;

EID: 84869752243     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1024533212Z.000000000144     Document Type: Article

References (28)

1. Perry DJ. Factor VII deficiency. Br J Haematol. 2002;118(3): 689-700.
2. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med. 1978;91:387-95.
3. Girolami A, Patrassi G, Cappellato G, Casonato A. Another family with the factor VII Padua clotting defect. Acta Haematol. 1979;62:4-11.
4. James HL, Kumar A, Girolami A, Hubbard J, Fair DS. Variant coagulation factors X and VII with point mutations in a highly conserved motif in the substrate binding pocket. Comparative molecular modelling. Thromb Haemost. 1991;65(Suppl.):932 (abstract).
5. O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, et al. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood. 1991;78:132-40.
6. James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VII Padua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta. 1993;1172:301-5.
7. Shurafa MS, Kumar A, Fair DS, James HL. The molecular defect in factor VII Detroit is due to substitution of Arg (304) by Glu. FASEB J. 1993;7:115 (abstract).
8. Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia. 1997; 3:242-6.
9. Horellou MH, Chalendard J, Juin F, Conard J, Gouault-Heilmann M, Tapon-Bretaudière J. Source of tissue factor leading to discrepant plasma FVII levels in eight FVII-deficient patients of African origin. J Thromb Haemost. 2007;5(Suppl. 2): P-M-002.
10. Kirkel D, Lin TW, Fu SW, Dlott JS, Sahud MA, McCaffrey T, et al. Asymptomatic factor VII deficiency: gene analysis and structure-function relationships. Blood Coagul Fibrinolysis. 2010;21:91-4.
11. Girolami A, Bert de Marinis G, Bonamigo E. Diagnosis of FVII Padua (Arg304Gln) by means of simple clotting tests. Clin Chim Acta. 2010;411:2107-8.
12. Girolami A. Ox-brain versus rabbit brain thromboplastin assays are the best tool for a preliminary diagnosis of the Arg304Gln FVII defect (FVII Padua). Acta Haematol. 2010;124:229-34.
13. Takamiya O, Abe S, Yoshioka A, Nakajima K, McVey JH, Tuddenham EG. Factor VII Shinjo: a dysfunctional factor VII variant homozygous for the substitution Gln for Arg at position 79. Haemostasis. 1995;25:89-97.
14. Takamiya O, Takeuchi S. Dysfunctional factor VII variant (FVII Tondabayashi) with R79Q: determination of mutated site with monoclonal anti-human factor VII antibody (B101/B1). Clin Chem. 1998;44:1993-5.
15. Greenberg DL, Davie EW. The blood coagulation factors: their complementary DNA, genes and expression. In: Colman RW, Hirsh J, Marder VJ, Clower AW, George JN, Goldhaber S, (eds.) Hemostasis and thrombosis. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 21.
16. Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA. 1996;93: 14379-84.
17. Chaing S, Clarke B, Sridhara S, Chu K, Friedman P, VanDusen W, et al. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Blood. 1994;83:3524-35.
18. Clarke BJ, Ofosu FA, Sridhara S, Bona RD, Rickles FR, Blajchman MA. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Lett. 1992;298:206-10.
19. O'Brien DP, Kemball-Cook G, Hutchinson AM, Martin DM, Johnson DJ, Byfield PG, et al. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). Biochemistry. 1994;33: 14162-9.
20. Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, et al. Molecular defects in CRM+factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol. 1994;86:610-8.
21. Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304→Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem. 1994;269: 7355-63.
22. Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, et al. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost. 2000; 84:250-7.
23. Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, et al. Greifswald factor FVII deficiency study group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009;15:267-80.
24. Millar DS, Kemball-Cook G, McVey JH, Tuddenham EG, Mumford AD, Attock GB, et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet. 2000;107:327-42.
25. Zheng DQ, Shurafa M, James HL. Factor VII G331D: a variant molecule involving replacement of a residue in the substrate-binding region of the catalytic domain. Blood Coagul Fibrinolysis. 1996;7:93-6.
26. Rodrigues DN, Siqueira LH, Galizoni AM, Arruda VR, Annichino-Bizzacchi JM. Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients. Blood Coagul Fibrinolysis. 2003;14:289-92.
27. Giansily-Blaizot M, Schved JF. Potential predictors of bleeding risk in inherited factor VII deficiency. Clinical, biological and molecular criteria. Thromb Haemost. 2005;94:901-6.
28. Girolami A, Sartori MT, Steffan A, Fadin MA. Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin. Blood Coagul Fibrinolysis. 1993;4:497-8.